CEFOTAXIME SODIUM — all Canadian products
9 DINs
6 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is CEFOTAXIME SODIUM, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02352168 | CEFOTAXIME SODIUM FOR INJECTION BP | AUROBINDO PHARMA LIMITED (UNIT VI) | Powder For Solution | Intramuscular; Intravenous | CEFOTAXIME SODIUM 0.5 G | Approved | |
| 02352184 | CEFOTAXIME SODIUM FOR INJECTION BP | AUROBINDO PHARMA LIMITED (UNIT VI) | Powder For Solution | Intramuscular; Intravenous | CEFOTAXIME SODIUM 2 G | Approved | |
| 02352176 | CEFOTAXIME SODIUM FOR INJECTION BP | AUROBINDO PHARMA LIMITED (UNIT VI) | Powder For Solution | Intravenous; Intramuscular | CEFOTAXIME SODIUM 1 G | Approved | |
| 02434105 | CEFOTAXIME SODIUM FOR INJECTION, BP | STERIMAX INC | Powder For Solution | Intravenous; Intramuscular | CEFOTAXIME SODIUM 2 G | Marketed | |
| 02434083 | CEFOTAXIME SODIUM FOR INJECTION, BP | STERIMAX INC | Powder For Solution | Intravenous; Intramuscular | CEFOTAXIME SODIUM 500 MG | Approved | |
| 02434091 | CEFOTAXIME SODIUM FOR INJECTION, BP | STERIMAX INC | Powder For Solution | Intramuscular; Intravenous | CEFOTAXIME SODIUM 1 G | Marketed | |
| 02225093 | CLAFORAN - PWS INJ 1.0G/VIAL | SANOFI-AVENTIS CANADA INC | Powder For Solution | Intravenous; Intramuscular | CEFOTAXIME SODIUM 1 G | Cancelled Post Market | |
| 02225107 | CLAFORAN - PWS INJ 2.0G/VIAL | SANOFI-AVENTIS CANADA INC | Powder For Solution | Intramuscular; Intravenous | CEFOTAXIME SODIUM 2 G | Cancelled Post Market | |
| 02225085 | CLAFORAN - PWS INJ 500MG/VIAL | SANOFI-AVENTIS CANADA INC | Powder For Solution | Intramuscular; Intravenous | CEFOTAXIME SODIUM 500 MG | Cancelled Post Market |
Browse other molecules: